Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems

Methods Mol Biol. 2016:1416:375-88. doi: 10.1007/978-1-4939-3584-0_22.

Abstract

The therapeutic potential of mesenchymal stem/stromal cells (MSC) has triggered the need for high cell doses in a vast number of clinical applications. This demand requires the development of good manufacturing practices (GMP)-compliant ex vivo expansion protocols that should be effective to deliver a robust and reproducible supply of clinical-grade cells in a safe and cost-effective manner. Controlled stirred-tank bioreactor systems under xenogeneic (xeno)-free culture conditions offer ideal settings to develop and optimize cell manufacturing to meet the standards and needs of human MSC for cellular therapies. Herein we describe two microcarrier-based stirred culture systems using spinner flasks and controlled stirred-tank bioreactors under xeno-free conditions for the efficient ex vivo expansion of human bone marrow and adipose tissue-derived MSC.

Keywords: Ex vivo expansion; Mesenchymal stem/stromal cells; Microcarriers; Scale-up; Spinner flask; Stirred-tank bioreactor; Xenogeneic-free.

MeSH terms

  • Bioreactors
  • Cell Culture Techniques / instrumentation*
  • Cell Culture Techniques / methods
  • Cell Differentiation
  • Cell Proliferation
  • Guideline Adherence
  • Humans
  • Immunophenotyping
  • Manufactured Materials / standards*
  • Mesenchymal Stem Cells / cytology*